tadalafil has been researched along with Dextro-Looped Transposition of the Great Arteries in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Beitzke, D; Bouchardy, J; Buechel, RR; Engel, R; Freese, M; Frenk, A; Gabriel, H; Greutmann, M; Haaf, P; Heg, D; Mueller, C; Possner, M; Ruperti-Repilado, FJ; Rutz, T; Schwerzmann, M; Schwitter, J; Schwitz, F; Tobler, D; Trachsel, L; Valsangiacomo Buechel, E; Willhelm, M; Wustmann, K | 1 |
Bouchardy, J; Buechel, RR; Freese, M; Frenk, A; Gabriel, H; Greutmann, M; Heg, D; Müller, C; Reto, E; Rutz, T; Schwerzmann, M; Schwitter, J; Tobler, D; Trachsel, L; Willhelm, M | 1 |
2 trial(s) available for tadalafil and Dextro-Looped Transposition of the Great Arteries
Article | Year |
---|---|
Effect of phosphodiesterase-5 inhibition on SystEmic Right VEntricular size and function. A multicentre, double-blind, randomized, placebo-controlled trial: SERVE.
Topics: Adult; Cyclic Nucleotide Phosphodiesterases, Type 5; Double-Blind Method; Female; Heart Failure; Heart Ventricles; Humans; Middle Aged; Stroke Volume; Tadalafil; Transposition of Great Vessels; Ventricular Function, Right | 2023 |
Effect of phosphodiesterase-5 inhibition with Tadalafil on SystEmic Right VEntricular size and function - A multi-center, double-blind, randomized, placebo-controlled clinical trial - SERVE trial - Rational and design.
Topics: Double-Blind Method; Heart Ventricles; Humans; Phosphodiesterase 5 Inhibitors; Tadalafil; Transposition of Great Vessels; Treatment Outcome; Ventricular Function, Right | 2017 |